Clinical Trial Update: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating anti-thrombotic strategies in patients getting coronary drug-eluting stents has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Samsung Medical Center | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED